{
    "Trade/Device Name(s)": [
        "MONOLISA\u2122 Anti-HAV EIA"
    ],
    "Submitter Information": "Bio-Rad",
    "510(k) Number": "K063318",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LOL"
    ],
    "Summary Letter Date": "March 21, 2007",
    "Summary Letter Received Date": "April 3, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3310"
    ],
    "Regulation Name(s)": [
        "Hepatitis A Virus (HAV) Serological Reagents"
    ],
    "Analyte Class(es)": [
        "immunology",
        "virology",
        "serology"
    ],
    "Analyte(s)": [
        "Total anti-HAV antibodies (IgG and IgM)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube",
        "Citrate tube",
        "ACD tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Competitive assay format",
        "Spectrophotometry"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Reagent",
        "Calibrator",
        "Control",
        "Consumable",
        "Buffer",
        "Wash solution",
        "Substrate",
        "Conjugate",
        "Antibody"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad MONOLISA\u2122 Anti-HAV EIA enzyme immunoassay kit for qualitative detection of total antibodies to Hepatitis A virus in human serum or plasma",
    "Indications for Use Summary": "Intended for qualitative detection of total antibodies (IgG and IgM) to Hepatitis A Virus (anti-HAV) in human adult and pediatric serum or plasma as an aid in diagnosing acute or past HAV infection and identifying HAV-susceptible individuals for vaccination; not intended for donor screening.",
    "fda_folder": "Microbiology"
}